株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

核医学治療薬の世界市場:成長動向・競合分析 (2020-2026年)

Global Therapeutic Nuclear Medicines Industry Research Report Growth Trends and Competitive Analysis 2020-2026

発行 QYResearch 商品コード 927398
出版日 ページ情報 英文 131 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.96円で換算しております。
核医学治療薬の世界市場:成長動向・競合分析 (2020-2026年) Global Therapeutic Nuclear Medicines Industry Research Report Growth Trends and Competitive Analysis 2020-2026
出版日: 2020年03月06日 ページ情報: 英文 131 Pages
概要

世界の核医学治療薬市場は、2019年に10億2,700万米ドルの規模となり、2026年までに24億7,700万米ドルに達すると予測されています。予測期間中のCAGRは13.83%が見込まれています。

当レポートでは、世界の核医学治療薬市場を調査し、市場規模 (実績と予測) 、地域別の主要データのほか、世界市場の状況、競合情勢、市場シェア、成長率、将来動向、市場促進要因、機会と課題、販売チャネルなど、体系的な情報を提供しています。

第1章 調査概要

  • 調査範囲
  • 調査対象メーカー:収益別
  • 市場区分:種類別
    • 世界の核医学治療薬の市場規模:種類別
    • ラジウム223
    • ルテチウム177
    • ヨウ素131
  • 市場区分:用途別
    • 世界の核医学治療薬の消費:用途別
    • 甲状腺
    • 骨移転
    • 悪性リンパ腫
  • 分析対象
  • 分析期間

第2章 世界市場の展望

  • 世界市場の分析
    • 生産額
    • 生産高
  • 世界市場規模の成長可能性:主要な生産地域別
    • 市場規模:主要な生産地域別
    • 市場シェア:主要な生産地域別
  • 産業動向
    • 市場の主な動向
    • 市場促進要因

第3章 市場シェア:メーカー別

  • 世界の主要メーカー:生産高別
  • 世界の主要メーカー:収益別
  • 平均販売価格 (ASP):メーカー別
  • 主要メーカーの工場分布・対象地域
  • 主要メーカーの市場参入日
  • 主要メーカーの提供製品
  • M&A、拡張計画

第4章 市場規模の推計・予測:種類別

  • 世界市場の規模:種類別
  • 世界市場規模の予測:種類別

第5章 市場規模:用途別

  • 消費:用途別
  • 消費予測:用途別

第6章 生産:地域別 - 市場データ

  • 世界の生産実績:地域別
  • 世界の生産額実績:地域別
  • 北米
  • 欧州
  • 中国

第7章 消費:地域別 - 市場データ

  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第8章 企業プロファイル

  • Novartis AG
  • Bayer
  • China Isotope & Radiation
  • Q BioMed
  • Curium Pharmaceuticals
  • Jubilant DraxImage
  • Dongcheng
  • Lantheus
  • Acrotech Biopharma
  • Progenics Pharmaceuticals
  • International Isotopes

第9章 生産予測:生産地域/国別

  • 生産額の予測:地域別
  • 生産予測:地域別
  • 主要生産地域の予測
    • 北米
    • 欧州
    • 中国

第10章 消費予測:主要消費地域/国別

  • 消費予測
  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第11章 バリューチェーン・販売チャネル分析

第12章 機会と課題、脅威と影響要因

第13章 主な調査結果

第14章 付録

図表

List of Tables and Figures

  • Table 1. Therapeutic Nuclear Medicines Key Market Segments 1
  • Table 2. Ranking of Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue (US$ Million) in 2019 3
  • Table 3. Global Therapeutic Nuclear Medicines Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million) 4
  • Table 4. Major Manufacturers of Radium-223 5
  • Table 5. Major Manufacturers of Lutetium-177 5
  • Table 6. Major Manufacturers of Iodine-131 6
  • Table 7. Global Therapeutic Nuclear Medicines Consumption by Application (K Units): 2015 VS 2020 VS 2026 6
  • Table 8. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Region: 2015 VS 2021 VS 2026 (US$ Million) 12
  • Table 9. Market Top Trends 13
  • Table 10. Key Drivers: Impact Analysis (2021-2026) 14
  • Table 11. Global Therapeutic Nuclear Medicines Production by Manufacturers (2019-2020) (K Units) 15
  • Table 12. Global Therapeutic Nuclear Medicines Production Share by Manufacturers (2019-2020) 15
  • Table 13. Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2019-2020) (US$ Million) 17
  • Table 14. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2019-2020) 17
  • Table 15. Global Therapeutic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI) 19
  • Table 16. Global Therapeutic Nuclear Medicines Average Selling Price (ASP) by Manufacturers (2019-2020) (USD/Unit) 19
  • Table 17. Key Manufacturers Therapeutic Nuclear Medicines Plants/Factories Distribution 20
  • Table 18. Key Manufacturers Therapeutic Nuclear Medicines Area Served 20
  • Table 19. Date of Key Manufacturers Enter into Therapeutic Nuclear Medicines Market 21
  • Table 20. Key Manufacturers Therapeutic Nuclear Medicines Product Type 21
  • Table 21. Mergers & Acquisitions, Expansion Plans 22
  • Table 22. Global Therapeutic Nuclear Medicines Production by Type (2015-2020) (K Units) 25
  • Table 23. Global Therapeutic Nuclear Medicines Production Share by Type (2015-2020) 25
  • Table 24. Global Therapeutic Nuclear Medicines Production Value by Type (2015-2020) (US$ Million) 27
  • Table 25. Global Therapeutic Nuclear Medicines Production Value Share by Type (2015-2020) 27
  • Table 26. Therapeutic Nuclear Medicines Average Selling Price (ASP) by Type (2015-2020) (USD/Unit) 29
  • Table 27. Global Therapeutic Nuclear Medicines Production Forecast by Type (2021-2026) (K Units) 29
  • Table 28. Global Therapeutic Nuclear Medicines Production Share Forecast by Type (2021-2026) 29
  • Table 29. Global Therapeutic Nuclear Medicines Production Value Forecast by Type (2021-2026) (US$ Million) 30
  • Table 30. Global Therapeutic Nuclear Medicines Production Value Share Forecast by Type (2021-2026) 30
  • Table 31. Global Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) 32
  • Table 32. Global Therapeutic Nuclear Medicines Consumption Share by Application (2015-2020) 32
  • Table 33. Global Therapeutic Nuclear Medicines Consumption by Application (2021-2026) (K Units) 33
  • Table 34. Global Therapeutic Nuclear Medicines Consumption Share by Application (2021-2026) 33
  • Table 35. Global Therapeutic Nuclear Medicines Production by Region (2015-2020) (K Units) 35
  • Table 36. Global Therapeutic Nuclear Medicines Production Market Share by Region (2015-2020) 35
  • Table 37. Global Therapeutic Nuclear Medicines Production Value by Region (2015-2020) (US$ Million) 36
  • Table 38. Global Therapeutic Nuclear Medicines Production Value Market Share by Region (2015-2020) 36
  • Table 39. Key Therapeutic Nuclear Medicines Players in North America 39
  • Table 40. Therapeutic Nuclear Medicines Import & Export (K Units) in North America (2015-2020) 39
  • Table 41. Key Therapeutic Nuclear Medicines Players in Europe 41
  • Table 42. Therapeutic Nuclear Medicines Import & Export (K Units) in Europe (2015-2020) 41
  • Table 43. Key Therapeutic Nuclear Medicines Players in China 43
  • Table 44. Therapeutic Nuclear Medicines Import & Export (K Units) in China (2015-2020) 43
  • Table 45. Global Therapeutic Nuclear Medicines Consumption by Region (2015-2020) (K Units) 44
  • Table 46. Global Therapeutic Nuclear Medicines Consumption Market Share by Region (2015-2020) 44
  • Table 47. North America Therapeutic Nuclear Medicines Consumption by Type (2015-2020) (K Units) 46
  • Table 48. North America Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) 46
  • Table 49. North America Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019 47
  • Table 50. North America Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units) 47
  • Table 51. Europe Therapeutic Nuclear Medicines Consumption by Type (2015-2020) (K Units) 50
  • Table 52. Europe Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) 50
  • Table 53. Europe Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units) 50
  • Table 54. Asia Pacific Therapeutic Nuclear Medicines Consumption by Type (2015-2020) (K Units) 54
  • Table 55. Asia Pacific Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) 54
  • Table 56. Asia Pacific Therapeutic Nuclear Medicines Consumption by Region (2015-2020) (K Units) 54
  • Table 57. Asia Pacific Therapeutic Nuclear Medicines Consumption Market Share by Region (2015-2020) 55
  • Table 58. South America Therapeutic Nuclear Medicines Consumption by Type (2015-2020) (K Units) 59
  • Table 59. South America Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) 59
  • Table 60. South America Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units) 59
  • Table 61. Middle East and Africa Therapeutic Nuclear Medicines Consumption by Type (2015-2020) (K Units) 61
  • Table 62. Middle East and Africa Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) 62
  • Table 63. Middle East and Africa Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units) 62
  • Table 64. Novartis AG Corporation Information 64
  • Table 65. Novartis AG Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 65
  • Table 66. Bayer Corporation Information 66
  • Table 67. Bayer Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 67
  • Table 68. China Isotope & Radiation Corporation Information 68
  • Table 69. China Isotope & Radiation Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 68
  • Table 70. Q BioMed Corporation Information 69
  • Table 71. Q BioMed Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 70
  • Table 72. Curium Pharmaceuticals Corporation Information 71
  • Table 73. Curium Pharmaceuticals Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 72
  • Table 74. Jubilant DraxImage Corporation Information 73
  • Table 75. Jubilant DraxImage Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 74
  • Table 76. Dongcheng Corporation Information 75
  • Table 77. Dongcheng Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 76
  • Table 78. Dongcheng Therapeutic Nuclear Medicines Products 76
  • Table 79. Lantheus Corporation Information 77
  • Table 80. Lantheus Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 78
  • Table 81. Lantheus Therapeutic Nuclear Medicines Products 78
  • Table 82. Acrotech Biopharma Corporation Information 79
  • Table 83. Acrotech Biopharma Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 79
  • Table 84. Progenics Pharmaceuticals Corporation Information 80
  • Table 85. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 81
  • Table 86. International Isotopes Corporation Information 82
  • Table 87. International Isotopes Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2020) 83
  • Table 88. Global Therapeutic Nuclear Medicines Production Value Forecast by Region (2021-2026) (US$ Million) 85
  • Table 89. Global Therapeutic Nuclear Medicines Production Value Share Forecast by Region (2021-2026) 85
  • Table 90. Global Therapeutic Nuclear Medicines Production Forecast by Region (2021-2026) (K Units) 86
  • Table 91. Global Therapeutic Nuclear Medicines Production Share Forecast by Region (2021-2026) 86
  • Table 92. Global Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026) (K Units) 91
  • Table 93. Global Therapeutic Nuclear Medicines Consumption Share Forecast by Region (2021-2026) 91
  • Table 94. North America Therapeutic Nuclear Medicines Consumption Forecast by Country (2021-2026) (K Units) 92
  • Table 95. Europe Therapeutic Nuclear Medicines Consumption Forecast by Country 2021-2026 (K Units) 93
  • Table 96. Asia Pacific Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026) (K Units) 94
  • Table 97. South America Therapeutic Nuclear Medicines Consumption Forecast by Country 2021-2026 (K Units) 96
  • Table 98. Middle East and Africa Therapeutic Nuclear Medicines Consumption Forecast by Country 2021-2026 (K Units) 97
  • Table 99. Therapeutic Nuclear Medicines Distributors List 100
  • Table 100. Therapeutic Nuclear Medicines Customers List 102
  • Table 101. Key Opportunities 104
  • Table 102. Key Challenges 105
  • Table 103. Research Programs/Design for This Report 108
  • Table 104. Key Data Information from Secondary Sources 111
  • Table 105. Key Data Information from Primary Sources 113
  • Figure 1. Therapeutic Nuclear Medicines Product Picture 1
  • Figure 2. Global Therapeutic Nuclear Medicines Production Market Share by Type in 2019 4
  • Figure 3. Radium-223 Product Picture 5
  • Figure 4. Lutetium-177 Product Picture 5
  • Figure 5. Iodine-131 Product Picture 6
  • Figure 6. Global Therapeutic Nuclear Medicines Market Share by Application in 2019 7
  • Figure 7. Thyroid Use Case 7
  • Figure 8. Bone Metastasis Use Case 8
  • Figure 9. Lymphoma Use Case 8
  • Figure 10. Therapeutic Nuclear Medicines Report Years Considered 9
  • Figure 11. Global Therapeutic Nuclear Medicines Production Value Growth Rate (2015-2026) (US$ Million) 11
  • Figure 12. Global Therapeutic Nuclear Medicines Production (2015-2026) (K Units) 12
  • Figure 13. Global Therapeutic Nuclear Medicines Market Share by Region: 2019 VS 2026 13
  • Figure 14. Global Therapeutic Nuclear Medicines Production Share by Manufacturers in 2019 16
  • Figure 15. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers in 2019 18
  • Figure 16. Global Therapeutic Nuclear Medicines Production Market Share by Type (2015-2020) 26
  • Figure 17. Global Therapeutic Nuclear Medicines Production Market Share by Type in 2019 26
  • Figure 18. Global Therapeutic Nuclear Medicines Production Value Market Share by Type (2015-2020) 28
  • Figure 19. Global Therapeutic Nuclear Medicines Production Value Market Share by Type in 2019 28
  • Figure 20. Global Therapeutic Nuclear Medicines Production Market Share Forecast by Type (2021-2026) 30
  • Figure 21. Global Therapeutic Nuclear Medicines Production Value Market Share Forecast by Type (2021-2026) 31
  • Figure 22. Global Consumption Therapeutic Nuclear Medicines Market Share by Application in 2019 33
  • Figure 23. Global Consumption Therapeutic Nuclear Medicines Market Share by Application in 2026 34
  • Figure 24. Global Therapeutic Nuclear Medicines Production Market Share by Region (2015-2020) 36
  • Figure 25. Global Therapeutic Nuclear Medicines Production Value Market Share by Region (2015-2020) 37
  • Figure 26. North America Therapeutic Nuclear Medicines Production Growth Rate 2015-2020 (K Units) 38
  • Figure 27. North America Therapeutic Nuclear Medicines Production Value Growth Rate 2015-2020 (US$ Million) 39
  • Figure 28. Europe Therapeutic Nuclear Medicines Production Growth Rate 2015-2020 (K Units) 40
  • Figure 29. Europe Therapeutic Nuclear Medicines Production Value Growth Rate 2015-2020 (US$ Million) 41
  • Figure 30. China Therapeutic Nuclear Medicines Production Growth Rate 2015-2020 (K Units) 42
  • Figure 31. China Therapeutic Nuclear Medicines Production Value Growth Rate 2015-2020 (US$ Million) 43
  • Figure 32. Global Therapeutic Nuclear Medicines Consumption Market Share by Region (2015-2020) 45
  • Figure 33. Global Therapeutic Nuclear Medicines Consumption Market Share by Region in 2019 45
  • Figure 34. North America Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 46
  • Figure 35. North America Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019 47
  • Figure 36. U.S. Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 48
  • Figure 37. Canada Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 48
  • Figure 38. Mexico Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 49
  • Figure 39. Europe Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 49
  • Figure 40. Germany Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 51
  • Figure 41. France Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 51
  • Figure 42. U.K. Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 52
  • Figure 43. Italy Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 52
  • Figure 44. Russia Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 53
  • Figure 45. Asia Pacific Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 53
  • Figure 46. China Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 55
  • Figure 47. Japan Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 56
  • Figure 48. South Korea Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 56
  • Figure 49. India Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 57
  • Figure 50. Australia Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 57
  • Figure 51. Southeast Asia Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 58
  • Figure 52. South America Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 58
  • Figure 53. Brazil Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 60
  • Figure 54. Argentina Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 60
  • Figure 55. Middle East and Africa Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 61
  • Figure 56. Middle East Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 63
  • Figure 57. Africa Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units) 63
  • Figure 58. Novartis AG Therapeutic Nuclear Medicines Products 65
  • Figure 59. Bayer Therapeutic Nuclear Medicines Products 67
  • Figure 60. China Isotope & Radiation Therapeutic Nuclear Medicines Products 69
  • Figure 61. Q BioMed Therapeutic Nuclear Medicines Products 71
  • Figure 62. Curium Pharmaceuticals Therapeutic Nuclear Medicines Products 72
  • Figure 63. Jubilant DraxImage Therapeutic Nuclear Medicines Products 74
  • Figure 64. Acrotech Biopharma Therapeutic Nuclear Medicines Products 80
  • Figure 65. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Products 82
  • Figure 66. International Isotopes Therapeutic Nuclear Medicines Products 84
  • Figure 67. Global Therapeutic Nuclear Medicines Production Value Market Share Forecast by Region (2021-2026) 86
  • Figure 68. Global Therapeutic Nuclear Medicines Production Market Share Forecast by Region (2021-2026) 87
  • Figure 69. North America Therapeutic Nuclear Medicines Production Forecast 2021-2026 (K Units) 87
  • Figure 70. North America Therapeutic Nuclear Medicines Revenue Forecast 2021-2026 (US$ Million) 88
  • Figure 71. Europe Therapeutic Nuclear Medicines Production Forecast 2021-2026 (K Units) 88
  • Figure 72. Europe Therapeutic Nuclear Medicines Revenue Forecast 2021-2026 (US$ Million) 89
  • Figure 73. China Therapeutic Nuclear Medicines Production Forecast 2021-2026 (K Units) 89
  • Figure 74. China Therapeutic Nuclear Medicines Revenue Forecast 2021-2026 (US$ Million) 90
  • Figure 75. North America Therapeutic Nuclear Medicines Consumption Year-over-year (YOY) Growth (2021-2026) (K Units) 92
  • Figure 76. Europe Therapeutic Nuclear Medicines Consumption Year-over-year (YOY) Growth (2021-2026) (K Units) 93
  • Figure 77. Asia Pacific Therapeutic Nuclear Medicines Consumption Year-over-year (YOY) Growth (2021-2026) (K Units) 94
  • Figure 78. South America Therapeutic Nuclear Medicines Consumption Year-over-year (YOY) Growth (2021-2026) (K Units) 95
  • Figure 79. Middle East and Africa Therapeutic Nuclear Medicines Consumption Year-over-year (YOY) Growth (2021-2026) (K Units) 96
  • Figure 80. Therapeutic Nuclear Medicines Value Chain 98
  • Figure 81. Channels of Distribution 100
  • Figure 82. Distributors Profiles 101
  • Figure 83. Porter's Five Forces Analysis 106
  • Figure 84. Bottom-up and Top-down Approaches for This Report 110
  • Figure 85. Data Triangulation 111
  • Figure 86. Key Executives Interviewed 113
目次

Market Overview:

The Therapeutic Nuclear Medicines market was valued at US$ 1027 million in 2019 and is projected to reach US$ 2477 million by 2026, at a CAGR of 13.83% during the forecast period. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Therapeutic Nuclear Medicines.

In terms of production side, this report researches the Therapeutic Nuclear Medicines production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.

In terms of consumption side, this report focuses on the consumption of Therapeutic Nuclear Medicines by regions (countries) and by Application.

The global Therapeutic Nuclear Medicines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Therapeutic Nuclear Medicines market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

By Company

  • Novartis AG
  • Bayer
  • China Isotope & Radiation
  • Q BioMed
  • Curium Pharmaceuticals
  • Jubilant DraxImage
  • Dongcheng
  • Lantheus
  • Acrotech Biopharma.
  • Progenics Pharmaceuticals
  • International Isotopes

Segment by Type

  • Radium-223
  • Lutetium-177
  • Iodine-131
  • Other

Segment by Application

  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Other

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Southeast Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • South America
    • Brazil
    • Argentina
  • Middle East & Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 REPORT OVERVIEW 1

  • 1.1 Research Scope 1
  • 1.2 Top Therapeutic Nuclear Medicines Manufacturers Covered: Ranking by Revenue 2
  • 1.3 Market Segment by Type 3
    • 1.3.1 Global Therapeutic Nuclear Medicines Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million) 4
    • 1.3.2 Radium-223 4
    • 1.3.3 Lutetium-177 5
    • 1.3.4 Iodine-131 6
  • 1.4 Market Segment by Application 6
    • 1.4.1 Global Therapeutic Nuclear Medicines Consumption by Application: 2015 VS 2020 VS 2026 6
    • 1.4.2 Thyroid 7
    • 1.4.3 Bone Metastasis 8
    • 1.4.4 Lymphoma 8
  • 1.5 Study Objectives 9
  • 1.6 Years Considered 9

2 GLOBAL MARKET PERSPECTIVE 11

  • 2.1 Global Therapeutic Nuclear Medicines MarketAnalysis 11
    • 2.1.1 Global Therapeutic Nuclear Medicines Production Value (2015-2026) 11
    • 2.1.2 Global Therapeutic Nuclear Medicines Production (2015-2026) 12
  • 2.2 Global Therapeutic Nuclear Medicines Market Size Growth Potential by Key Producing Regions 12
    • 2.2.1 Global Therapeutic Nuclear Medicines Market Size by Key Producing Regions: 2015 VS 2021 VS 2026 12
    • 2.2.2 Global Therapeutic Nuclear Medicines Market Share by Key Producing Regions: 2019 VS 2026 13
  • 2.3 Industry Trends 13
    • 2.3.1 Market Top Trends 13
    • 2.3.2 Market Drivers 14

3 MARKET SHARE BY MANUFACTURERS 15

  • 3.1 Global Top Manufacturers by Therapeutic Nuclear Medicines Production 15
  • 3.2 Global Top Manufacturers by Therapeutic Nuclear Medicines Revenue 17
    • 3.2.1 Global Top Manufacturers by Therapeutic Nuclear Medicines Revenue (2019-2020) 17
    • 3.2.2 Global Top Manufacturers Market Share by Therapeutic Nuclear Medicines Revenue (2015-2020) 17
    • 3.2.3 Global Therapeutic Nuclear Medicines Market Concentration Ratio (CR5 and HHI) 19
  • 3.3 Global Therapeutic Nuclear Medicines Average Selling Price (ASP) by Manufacturers 19
  • 3.4 Key Manufacturers Therapeutic Nuclear Medicines Plants/Factories Distribution and Area Served 20
  • 3.5 Date of Key Manufacturers Enter into Therapeutic Nuclear Medicines Market 21
  • 3.6 Key Manufacturers Therapeutic Nuclear Medicines Product Offered 21
  • 3.7 Mergers & Acquisitions, Expansion Plans 22

4 ESTIMATES AND FORECASTS BY TYPE (2015-2026) 25

  • 4.1 Global Therapeutic Nuclear Medicines Historic Market Size by Type (2015-2020) 25
    • 4.1.1 Global Therapeutic Nuclear Medicines Production Market Share by Type (2015-2020) 25
    • 4.1.2 Global Therapeutic Nuclear Medicines Production Value Market Share by Type 27
    • 4.1.3 Global Therapeutic Nuclear Medicines Average Selling Price (ASP) by Type (2015-2020) 29
  • 4.2 Global Therapeutic Nuclear Medicines Market Size Forecast by Type (2021-2026) 29
    • 4.2.1 Global Therapeutic Nuclear Medicines Production Market Share Forecast by Type (2021-2026) 29
    • 4.2.2 Global Therapeutic Nuclear Medicines Production Value Market Share Forecast by Type 30

5 MARKET SIZE BY APPLICATION (2015-2026) 32

  • 5.1 Global Therapeutic Nuclear Medicines Consumption by Application (2015-2020) 32
  • 5.2 Global Therapeutic Nuclear Medicines Consumption by Application (2021-2026) 33

6 THERAPEUTIC NUCLEAR MEDICINES PRODUCTION BY REGION: MARKET FACTS & FIGURES 35

  • 6.1 Global Therapeutic Nuclear Medicines Production (History Data) by Region (2015-2020) 35
  • 6.2 Global Therapeutic Nuclear Medicines Production Value (History Data) by Region 36
  • 6.3 North America 38
    • 6.3.1 North America Therapeutic Nuclear Medicines Production Growth Rate 2015-2020 38
    • 6.3.2 North America Therapeutic Nuclear Medicines Production Value Growth Rate 2015-2020 39
    • 6.3.3 Key Therapeutic Nuclear Medicines Players in North America 39
    • 6.3.4 North America Therapeutic Nuclear Medicines Import & Export (2015-2020) 39
  • 6.4 Europe 40
    • 6.4.1 Europe Therapeutic Nuclear Medicines Production Growth Rate 2015-2020 40
    • 6.4.2 Europe Therapeutic Nuclear Medicines Production Value Growth Rate 2015-2020 41
    • 6.4.3 Key Therapeutic Nuclear Medicines Players in Europe 41
    • 6.4.4 Europe Therapeutic Nuclear Medicines Import & Export (2015-2020) 41
  • 6.5 China 42
    • 6.5.1 China Therapeutic Nuclear Medicines Production Growth Rate 2015-2020 42
    • 6.5.2 China Therapeutic Nuclear Medicines Production Value Growth Rate 2015-2020 43
    • 6.5.3 Key Therapeutic Nuclear Medicines Players in China 43
    • 6.5.4 China Therapeutic Nuclear Medicines Import & Export (2015-2020) 43

7 THERAPEUTIC NUCLEAR MEDICINES CONSUMPTION BY REGION: MARKET FACTS & FIGURES 44

  • 7.1 North America 46
    • 7.1.1 North America Therapeutic Nuclear Medicines Consumption by Type 46
    • 7.1.2 North America Therapeutic Nuclear Medicines Consumption by Application 46
    • 7.1.3 North America Therapeutic Nuclear Medicines Consumption by Countries 47
    • 7.1.4 U.S. 48
    • 7.1.5 Canada 48
    • 7.1.6 Mexico 49
  • 7.2 Europe 49
    • 7.2.1 Europe Therapeutic Nuclear Medicines Consumption by Type 50
    • 7.2.2 Europe Therapeutic Nuclear Medicines Consumption by Application 50
    • 7.2.3 Europe Therapeutic Nuclear Medicines Consumption by Countries 50
    • 7.2.4 Germany 51
    • 7.2.5 France 51
    • 7.2.6 U.K. 52
    • 7.2.7 Italy 52
    • 7.2.8 Russia 53
  • 7.3 Asia Pacific 53
    • 7.3.1 Asia Pacific Therapeutic Nuclear Medicines Consumption by Type 54
    • 7.3.2 Asia Pacific Therapeutic Nuclear Medicines Consumption by Application 54
    • 7.3.3 Asia Pacific Therapeutic Nuclear Medicines Consumption by Region 54
    • 7.3.4 China 55
    • 7.3.5 Japan 56
    • 7.3.6 South Korea 56
    • 7.3.7 India 57
    • 7.3.8 Australia 57
    • 7.3.9 Southeast Asia 58
  • 7.4 South America 58
    • 7.4.1 South America Therapeutic Nuclear Medicines Consumption by Type 59
    • 7.4.2 South America Therapeutic Nuclear Medicines Consumption by Application 59
    • 7.4.3 South America Therapeutic Nuclear Medicines Consumption by Countries 59
    • 7.4.4 Brazil 60
    • 7.4.5 Argentina 60
  • 7.5 Middle East and Africa 61
    • 7.5.1 Middle East and Africa Therapeutic Nuclear Medicines Consumption by Type 61
    • 7.5.2 Middle East and Africa Therapeutic Nuclear Medicines Consumption by Application 62
    • 7.5.3 Middle East and Africa Therapeutic Nuclear Medicines Consumption by Countries 62
    • 7.5.4 Middle East 63
    • 7.5.5 Africa 63

8 COMPANY PROFILES 64

  • 8.1 Novartis AG 64
    • 8.1.1 Novartis AG Corporation Information 64
    • 8.1.2 Novartis AG Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 65
    • 8.1.3 Novartis AG Therapeutic Nuclear Medicines Products 65
  • 8.2 Bayer 66
    • 8.2.1 Bayer Corporation Information 66
    • 8.2.2 Bayer Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 67
    • 8.2.3 Bayer Therapeutic Nuclear Medicines Products 67
  • 8.3 China Isotope & Radiation 68
    • 8.3.1 China Isotope & Radiation Corporation Information 68
    • 8.3.2 China Isotope & Radiation Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 68
    • 8.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Products 69
  • 8.4 Q BioMed 69
    • 8.4.1 Q BioMed Corporation Information 69
    • 8.4.2 Q BioMed Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 70
    • 8.4.3 Q BioMed Therapeutic Nuclear Medicines Products 71
  • 8.5 Curium Pharmaceuticals 71
    • 8.5.1 Curium Pharmaceuticals Corporation Information 71
    • 8.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 72
    • 8.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Products 72
  • 8.6 Jubilant DraxImage 73
    • 8.6.1 Jubilant DraxImage Corporation Information 73
    • 8.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 74
    • 8.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Products 74
  • 8.7 Dongcheng 75
    • 8.7.1 Dongcheng Corporation Information 75
    • 8.7.2 Dongcheng Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 76
    • 8.7.3 Dongcheng Therapeutic Nuclear Medicines Products 76
  • 8.8 Lantheus 77
    • 8.8.1 Lantheus Corporation Information 77
    • 8.8.2 Lantheus Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 78
    • 8.8.3 Lantheus Therapeutic Nuclear Medicines Products 78
  • 8.9 Acrotech Biopharma 79
    • 8.9.1 Acrotech Biopharma Corporation Information 79
    • 8.9.2 Acrotech Biopharma Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 79
    • 8.9.3 Acrotech Biopharma Therapeutic Nuclear Medicines Products 80
  • 8.10 Progenics Pharmaceuticals 80
    • 8.10.1 Progenics Pharmaceuticals Corporation Information 80
    • 8.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 81
    • 8.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Products 82
  • 8.11 International Isotopes 82
    • 8.11.1 International Isotopes Corporation Information 82
    • 8.11.2 International Isotopes Therapeutic Nuclear Medicines Production Revenue, Average Selling Price (ASP) and Gross Margin (2019-2020) 83
    • 8.11.3 International Isotopes Therapeutic Nuclear Medicines Products 84

9 THERAPEUTIC NUCLEAR MEDICINES PRODUCTION SIDE BY PRODUCING REGIONS (COUNTRIES) 85

  • 9.1 Global Therapeutic Nuclear Medicines Production Value Forecast by Region (2021-2026) 85
  • 9.2 Global Therapeutic Nuclear Medicines Production Forecast by Region 86
  • 9.3 Key Therapeutic Nuclear Medicines Producing Regions Forecast 87
    • 9.3.1 North America 87
    • 9.3.2 Europe 88
    • 9.3.3 China 89

10 THERAPEUTIC NUCLEAR MEDICINES CONSUMPTION FORECAST BY TOP CONSUMERS (REGIONS/COUNTRIES) 91

  • 10.1 Global Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026) 91
  • 10.2 North America Therapeutic Nuclear Medicines Consumption YoY Growth Forecast 92
    • 10.2.1 North America Therapeutic Nuclear Medicines Consumption YoY Growth (2021-2026) 92
    • 10.2.2 North America Therapeutic Nuclear Medicines Consumption Forecast by Country (2021-2026) 92
  • 10.3 Europe Therapeutic Nuclear Medicines Consumption YoY Growth Forecast 93
    • 10.3.1 Europe Therapeutic Nuclear Medicines Consumption YoY Growth (2021-2026) 93
    • 10.3.2 Europe Therapeutic Nuclear Medicines Consumption Forecast by Country 2021-2026 93
  • 10.4 Asia Pacific Therapeutic Nuclear Medicines Consumption YoY Growth Forecast 94
    • 10.4.1 Asia Pacific Therapeutic Nuclear Medicines Consumption YoY Growth (2021-2026) 94
    • 10.4.2 Asia Pacific Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026) 94
  • 10.5 South America Therapeutic Nuclear Medicines Consumption YoY Growth Forecast 95
    • 10.5.1 South America Therapeutic Nuclear Medicines Consumption YoY Growth (2021-2026) 95
    • 10.5.2 South America Therapeutic Nuclear Medicines Consumption Forecast by Country 2021-2026 96
  • 10.6 Middle East and Africa Therapeutic Nuclear Medicines Consumption YoY Growth Forecast 96
    • 10.6.1 Middle East and Africa Therapeutic Nuclear Medicines Consumption YoY Growth (2021-2026) 96
    • 10.6.2 Middle East and Africa Therapeutic Nuclear Medicines Consumption Forecast by Country 2021-2026 97

11 VALUE CHAIN AND SALES CHANNELS ANALYSIS 98

  • 11.1 Value Chain Analysis 98
  • 11.2 Sales Channels Analysis 99
    • 11.2.1 Therapeutic Nuclear Medicines Sales Channels 99
    • 11.2.2 Therapeutic Nuclear Medicines Distributors 100
  • 11.3 Therapeutic Nuclear Medicines Customers 102

12 OPPORTUNITIES & CHALLENGES, THREAT AND AFFECTING FACTORS 104

  • 12.1 Market Opportunities 104
  • 12.2 Market Challenges 105
  • 12.3 Porter's Five Forces Analysis 105

13 KEY FINDINGS 107

14 APPENDIX 108

  • 14.1 Research Methodology 108
    • 14.1.1 Methodology/Research Approach 108
    • 14.1.2 Data Source 111
  • 14.2 Author Details 114
  • 14.3 Disclaimer 114